Sufferers who expertise recurrence of COVID-19 symptoms after finishing remedy with Pfizer’s drug Paxlovid ought to isolate once more for 5 days, the U.S. Centers for Disease Control and Prevention mentioned in an advisory issued on Tuesday.
Dozens of people have reported rebounding COVID signs on social media or to the U.S. Meals and Drug Administration after taking Paxlovid, however Pfizer suggests the expertise is uncommon. A latest rise in COVID circumstances has pushed up use of therapeutics within the nation.
The CDC mentioned in its advisory that case experiences recommend that recurrence ends in delicate signs, and there have been no experiences of extreme illness thus far. The company nonetheless continues to advocate the oral antiviral drug as a remedy, regardless of the potential for recurrences.
A short return of signs could also be a part of the pure historical past of SARS-CoV-2 an infection in some individuals, no matter remedy with Paxlovid, the company mentioned.
CDC recommends that sufferers with COVID rebound can finish their re-isolation interval after 5 full days if there isn’t a fever for twenty-four hours and signs enhance, however such sufferers ought to put on a masks for a complete of 10 days after rebound signs start.
Well being Canada approves COVID-19 remedy drug Paxlovid